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Introduction {#sec1}
============

Adult tissues are maintained through the regulated self-renewal and differentiation of stem cells that give rise to differentiated cell types. The mammary epithelium typifies this process by undergoing cyclic expansion and contraction during the estrous cycle and further differentiating during pregnancy and lactation ([@bib11], [@bib26], [@bib37]). This extensive tissue turnover demands a continuous source of newly minted differentiated cells of both the luminal and basal epithelial lineages. While the existence of both bipotent and lineage-restricted mammary stem cells (MaSCs) has been established ([@bib10], [@bib16], [@bib30], [@bib33], [@bib38], [@bib41], [@bib49], [@bib50], [@bib56], [@bib55], [@bib59], [@bib60]), relatively little is known about the genes that regulate the self-renewal or differentiation of these stem and progenitor cell types.

The identification of self-renewal and lineage commitment regulators in the human mammary gland has been complicated by two main factors. First, while cell surface markers often enrich for stem and more differentiated cell states, they rarely allow investigators to isolate pure subpopulations of mammary epithelial cells (MECs). The absence of definitive markers, particularly those distinguishing MaSCs from differentiated cells of the basal lineage, precludes the use of transcriptomic or other profiling strategies to identify candidate regulators that commit bipotent cells to the basal lineage. Second, while powerful transplantation and lineage tracing assays are available for study of the murine mammary gland, a lack of appropriate experimental models precludes similar analyses in human cells ([@bib59]). While the mouse has been indispensably valuable as an experimental model, murine mammary glands display morphological, developmental, and genomic differences when compared with the human gland ([@bib7], [@bib12], [@bib58]), suggesting that rodents may not fully replicate aspects of the biology of human mammary tissue. This latter limitation was partially addressed by the recent development of three-dimensional (3D) culture models that support the outgrowth of morphologically complex mammary tissue from primary human MECs ([@bib28], [@bib46]).

This study was motivated by the need for systematic methods to identify functional regulators of stem and progenitor cell states. We approached this problem by observing that genes whose expression is sufficient to specify a particular cell lineage would need to be stably repressed in other cell lineages to prevent aberrant differentiation ([@bib27], [@bib36], [@bib39], [@bib53]). In principle, this observation provides a means of distinguishing between downstream markers and key functional regulators of a cell state. Thus, in a mixed population of cells containing two cell lineages, genes sufficient to alter a cell\'s state would be stably repressed in one lineage and expressed in the other. Even though such genes would either be expressed or repressed in any given cell, profiling of a population of cells would show that such genes display epigenetic marks associated with both gene repression (histone H3K27me3) and active expression (histone H3K4me3) ([@bib5], [@bib17]).

We use an additional feature to distinguish such "pseudo-bivalent" genes (Ψ-bivalent), expressed in some cell types and repressed in others, from genes that are uniformly bivalent and thus poised for expression (though not actually expressed) in all of the cells within a population. At an epigenetic level, Ψ-bivalent genes can be distinguished from truly bivalent genes by markers of transcriptional elongation (histone H3K79me2) and the presence of transcribed mRNAs. We hypothesized that Ψ-bivalent genes encompass functionally significant regulators of stem cell self-renewal and lineage commitment. Here, we identify a cohort of such Ψ-bivalent genes in a mammary stem/progenitor cell line. We validate the role of one of these genes, *BCL11B*, in driving the self-renewal of primary human multipotent MaSCs in two-dimensional (2D) and 3D assays of progenitor activity, differentiation potential, and tissue development. Furthermore, we show that BCL11B functions to maintain *in vitro* multipotency by specifically inhibiting basal lineage commitment.

Results {#sec2}
=======

Identification of Pseudo-bivalent TFs as Candidate Cell Lineage Specifiers {#sec2.1}
--------------------------------------------------------------------------

To identify candidate genes regulating cell state, we used the MCF10A cell line as a model system ([@bib47]). When seeded into 3D collagen gels, single MCF10A cells can form morphologically complex ductal-lobular tissue rudiments (organoids) ([Figures 1](#fig1){ref-type="fig"}A and 1B), indicating that this line contains bipotent stem cells capable of differentiating and self-organizing into the tree-like architecture characteristic of mammary tissue. In addition to forming ductal-lobular organoids, single MCF10A cells also form either duct-only or lobule-only organoids, indicating the presence of lineage-committed progenitors ([Figure 1](#fig1){ref-type="fig"}B). Because this cell line contains the lineage-committed basal and luminal progenitor cell states required for tissue morphogenesis ([@bib19], [@bib35], [@bib45]), we set out to identify differentially expressed transcription factors (TFs) that may specify these states.Figure 1Discovery of Candidate Lineage Specifiers in the MCF10A Mammary Stem Cell Line(A) Schematic showing the seeding of MCF10A cells into 3D collagen cultures, and the formation of organoids.(B) Representative confocal microscopy images showing examples of MCF10A organoids after 8 days of 3D culture. Examples of acinar organoids are indicated with arrowheads, ductal organoids are indicated with arrows, and ductal-lobular organoids are indicated with asterisks. Scale bars, 50 μm.(C) Schematic depiction of epigenetic marks at active, repressed, bivalent, and Ψ-bivalent genes.(D) Representative results of ChIP-seq run for histone H3K4me3, histone H3K27me3, and histone H3K79me2, showing active, repressed, bivalent, and pseudo-bivalent genes in a mixed population of MCF10A cells.(E) Summary of bivalent and Ψ-bivalent TF loci calls from ChIP-seq and RT-PCR results.

While many factors are differentially expressed between cell states, we were interested specifically in factors capable of reprogramming cellular lineage. We reasoned that the promoters of such factors would be actively repressed in other lineages, since, if this were not the case, stochastic fluctuations in their expression could lead to inappropriate lineage switching. Thus, a factor capable of driving cells into lineage A would be expressed in cells of that lineage while stably repressed in other cell lineages. We identified such factors using chromatin immunoprecipitation sequencing (ChIP-seq) against histone modifications marking transcriptional activation (H3K4me3), transcriptional repression (H3K27me3), and active transcriptional elongation (H3K79me2) ([Figures 1](#fig1){ref-type="fig"}C and 1D).

Based on the above reasoning, we were interested specifically in finding Ψ-bivalent TFs that appeared bivalent on the population level but were in fact either expressed or repressed in individual cells ([Figure 1](#fig1){ref-type="fig"}C). These factors would be stably activated (H3K4me3^+^ promoter) in a subset of cells and stably repressed (H3K27me3^+^ promoter) in another subpopulation. We identified a total 1,895 H3K4me3^+^ TFs and 1,135 H3K27me3^+^ TFs. We identified 55 TFs whose promoters were marked with both H3K4me3 and H3K27me3 peaks on the population level (see [Experimental Procedures](#sec4){ref-type="sec"} for details on peak calling). Of these bivalent TFs, 23 also contained H3K79me2 peaks within their gene body, indicating active elongation, suggesting that the majority of these genes were expressed in a subset of cells. However, since H3K79 methylation status is regulated in part by cell cycle status ([@bib40]), to definitively identify genes being actively transcribed we performed RT-PCR, which revealed that 48 of the bivalent TFs expressed detectable mRNAs on the population level ([Table S1](#mmc1){ref-type="supplementary-material"} and [Figure 1](#fig1){ref-type="fig"}E). We classified these 48 TFs as Ψ-bivalent candidate regulators of differentiation.

Candidate Regulatory TFs Mark Cell States in the Human Mammary Gland {#sec2.2}
--------------------------------------------------------------------

To determine whether any of these candidate regulatory TFs play a role in human MEC identity, we asked whether their expression distinguishes mature cell types within the human gland *in vivo*. We collected single cells from elective patient reduction mammoplasty tissue and performed single-cell qPCR to quantify expression of the 48 candidate TFs, as well as established cell-state markers ([Figure 2](#fig2){ref-type="fig"}A). Using unsupervised hierarchical clustering ([Figure 2](#fig2){ref-type="fig"}B) and principal component dimensionality reduction ([Figure 2](#fig2){ref-type="fig"}C), the cells separated into three distinct clusters. Cells in two of the clusters expressed markers of the basal lineage (*CD10*, *SNAI1*, *SNAI2*, *ITGA6*) ([@bib4], [@bib29], [@bib35], [@bib50], [@bib57]), whereas a third cluster contained cells enriched for higher expression of luminal lineage markers (*EPCAM*, *GATA3*, *SOX9*, *KRT18*, *ETV6*) ([@bib1], [@bib2], [@bib13], [@bib18], [@bib42], [@bib51], [@bib52], [@bib54]) ([Figures 2](#fig2){ref-type="fig"}B and 2D).Figure 2Candidate Lineage Specifiers Distinguish Luminal and Basal Cell Types in Primary Human Mammary Epithelial Cells(A) Schematic depicting the isolation of patient mammary epithelial cells and single-cell qPCR.(B) Single-cell qPCR of established cell-state markers and candidate lineage-specifying TFs results in one luminal cluster and two basal clusters of cells.(C) Principal component analysis of single-cell gene expression data shows three distinct clusters of cells.(D) Enrichment of expression of each gene is plotted for each of the three clusters. Colored and labeled points indicate genes significantly enriched in a cluster, relative to cells outside of that cluster (p \< 0.01 by Wilcoxon rank-sum test).

Each of these three clusters showed statistically significant enrichment of expression of at least one of our candidate regulatory TFs (Wilcoxon rank-sum test, p \< 0.01; [Figure 2](#fig2){ref-type="fig"}D). The luminal cluster was enriched for expression of *ATF3*, *BARX2*, and *ZNF175*. Basal cluster 1, which expresses high levels of the epithelial to mesenchymal transition (EMT) TF, *SNAI1*, was also enriched for the expression of *FLI1*. Basal cluster 2, which expresses high levels of the basal markers *SNAI2* and *CD10*, was also enriched for the expression of another EMT TF, *ZEB2*. Notably, a recent study by [@bib3] identified a subpopulation of basal cells in the murine mammary gland that was also enriched for *Zeb2* expression, raising the possibility that basal cluster 2 represents a human homolog of this murine cell state. In summary, our findings raise the possibility that two distinct human basal epithelial cell types exist, which may be regulated by *FLI1* and *ZEB2*, respectively.

Candidate Regulatory TFs Are Enriched in Cultured Primary MaSCs {#sec2.3}
---------------------------------------------------------------

In order to determine whether any of these 48 candidate cell-state specifiers controlled the MaSC state, we first needed to enrich stem and progenitor cells from our patient sample. To do so, we used a recently described method ([@bib28], [@bib46]) of *in vitro* culture of freshly isolated primary cells in 3D hydrogels to expand stem and progenitor cells ([Figure 3](#fig3){ref-type="fig"}A). When grown in these hydrogels, single cells form simple 3D structures over the course of 14 days ([Figure 3](#fig3){ref-type="fig"}B). The cells within these immature structures are strongly enriched for stem/progenitor cell states, as demonstrated by a roughly 18-fold increase in colony formation when plated in 2D culture ([Figure 3](#fig3){ref-type="fig"}C). These cultured cells express higher levels of *KRT14*, indicating an expansion of the basal population, which contains all of the bipotent stem cell activity in the mammary epithelium. They also express higher levels of *SNAI2* and *SOX9*, whose co-expression is required for the stem cell state in the mouse mammary epithelium ([@bib13]) ([Figure 3](#fig3){ref-type="fig"}D).Figure 3Expansion of Primary Human Mammary Stem/Progenitor Cells in 3D Hydrogel Culture(A) Schematic showing the seeding of primary MECs in 2D colony-forming assays, before and after culture in 3D hydrogels, to assay stem/progenitor activity. 10d, 10 days; 14d, 14 days.(B) Representative brightfield microscopy images of tissue rudiments formed from single primary MECs. Scale bar, 100 μm.(C) Quantification of colony-forming efficiency in uncultured primary cells and 3D hydrogel-cultured cells. Data plotted are normalized to primary cells, and demonstrate a roughly 18-fold increase in stem/progenitor activity in cells cultured in 3D hydrogels (n = 3 independent experiments).(D) Gene expression, as determined by single-cell qPCR, in primary cells and 3D hydrogel-cultured cells. Expression values are gene normalized and set to a range from 0 to 1. Box and whiskers plot depicts the median, interquartile range, and minimum and maximum values.Error bars represent mean ± SD. ^∗^p \< 0.05 by Student\'s t test.

To determine whether any of our 48 candidate cell-state regulatory TFs were enriched in these cultured stem/progenitor cells, we performed single-cell qPCR. This analysis revealed two clusters of cultured cells: a basal cluster marked by enriched *ITGA6* and *KRT14* expression and a luminal cluster marked by enriched *EPCAM* expression ([Figure 4](#fig4){ref-type="fig"}A). Comparing expression of our candidate TFs in stem/progenitor cells with mature primary cells, we found four TFs with significantly increased expression in stem/progenitor cells: *BCL11B*, *HOXC13*, *LMX1B*, and *TCF7* ([Figure 4](#fig4){ref-type="fig"}B). Of these four genes, *BCL11B* was most restricted to the basal population, which contains the bipotent MaSCs ([Figure 4](#fig4){ref-type="fig"}C). We therefore set out to test the role of BCL11B in the differentiation and self-renewal of human MaSCs.Figure 4Expression of *BCL11B* Is Enriched in Human Mammary Stem/Progenitor Cells(A) Results of single-cell qPCR of established cell-state markers and candidate lineage-specifying TFs in primary MECs cultured in 3D hydrogels for 14 days. Cells separate into a cluster composed of basal stem/progenitor cells (indicated by co-expression of *SNAI2* and *SOX9*) and luminal progenitor cells (expressing *SOX9*, but not *SNAI2*).(B) Normalized gene expression of three cell-state markers (*EPCAM*, *GATA3*, and *ITGA6*) is not significantly changed, but four candidate lineage-specifying TFs (*BCL11B*, *TCF7*, *HOXC13*, and *LMX1B*) are significantly enriched (p \< 0.01 by Mann-Whitney test) in cultured MECs (3D hydrogel) relative to uncultured (primary) cells (n = 121 primary cells and 94 3D hydrogel-cultured cells).(C) Normalized gene expression of *BCL11B*, *TCF7*, *HOXC13*, and *LMX1B* in cultured cells from the two clusters is plotted (n = 64 basal cells and 30 luminal cells).

BCL11B Is Required for the Self-Renewal of 3D Cultured MCF10A Cells {#sec2.4}
-------------------------------------------------------------------

First, we examined the expression of BCL11B protein in MCF10A cells. As predicted by its epigenetic Ψ-bivalence, we found its expression to be heterogeneous, with some cells not detectably expressing protein and other expressing high levels of protein ([Figures 5](#fig5){ref-type="fig"}A and 5B). Next we set out to test the functional role of BCL11B in MCF10A cell self-renewal and differentiation. We used two independent short hairpin RNAs (shRNAs) to inhibit expression of BCL11B ([Figure 5](#fig5){ref-type="fig"}C), neither of which affected the growth rate of the cells in 2D culture ([Figure 5](#fig5){ref-type="fig"}D). When seeded into 3D culture, MCF10A cells with inhibited expression of BCL11B prematurely differentiate, as indicated by a reduction in organoid size ([Figures 5](#fig5){ref-type="fig"}E and 5F), failure to form acini ([Figures 5](#fig5){ref-type="fig"}E and 5G), and loss of ability to repopulate new organoids when reseeded into secondary 3D cultures ([Figure 5](#fig5){ref-type="fig"}H). These phenotypes all pointed toward a loss of MCF10A self-renewal upon inhibition of BCL11B when cells are grown in differentiating conditions (3D culture).Figure 5BCL11B Is Required for MCF10A Self-Renewal and Duct Formation(A) Immunofluorescent staining of BCL11B protein expression. Representative of three independent replicates. Scale bar, 50 μm.(B) Histogram showing quantification of BCL11B from (A) (n = 228 cells).(C) Demonstration of knockdown of *BCL11B* expression, by qPCR, in MCF10A cells (left) or primary patient MECs (right) transduced with two shRNAs. Plotted is expression relative to uninfected control, normalized to GAPDH (n = 4 independent experiments).(D) Growth curves showing no difference in growth rate of MCF10A cells transduced with shRNAs targeting *BCL11B* or *Luciferase* (shCntrl) (n = 3 independent experiments).(E) Representative images of MCF10A cells transduced with either shRNAs targeting *BCL11B* or *Luciferase* (shCntrl), grown in 3D culture for 7 days and stained with DAPI (blue) and phalloidin (green). Scale bars, 200 μm (n = 4 independent experiments).(F) Quantification of the size of organoids from (E) (n = 4 independent experiments).(G) Quantification of the ratio of ductal organoids to acinar organoids from (E) (n = 4 independent experiments).(H) Quantification of the fraction of MCF10A cells from the three lines that are capable of giving rise to secondary organoids after being removed from primary 3D culture and reseeded (n = 3 independent experiments).Error bars represent mean ± SD. ^∗^p \< 0.05 by Student\'s t test.

BCL11B Drives Primary Human MaSC Self-Renewal by Inhibiting Basal Differentiation {#sec2.5}
---------------------------------------------------------------------------------

To determine the role of BCL11B in the differentiation of primary human stem and progenitor cells *in vitro*, we performed a canonical 2D plate differentiation assay in wild-type patient cells and in cells transduced with shRNAs targeting *BCL11B*. Inhibition of BCL11B in two independent patient samples did not affect the formation of luminal colonies or mixed luminal-basal colonies. However, the fraction of bipotent stem cell colonies, identified in this assay by the presence of co-expression of luminal and basal markers ([@bib9], [@bib32], [@bib44], [@bib45], [@bib48]), dropped significantly, indicative of a loss of bipotent stem cell self-renewal in these *in vitro* conditions ([@bib23], [@bib31], [@bib34]). This was accompanied by a reciprocal increase in mature basal colonies, indicating that, rather than self-renewing, stem cells were differentiating into basal progenitors in the absence of BCL11B ([Figures 6](#fig6){ref-type="fig"}A and 6B).Figure 6BCL11B Drives Self-Renewal of Primary Human MaSCs by Inhibiting Basal Differentiation(A) Demonstration of automated colony-scoring pipeline and representative basal, luminal, mixed, and stem colonies derived from single primary human MECs grown for 10 days in 2D culture. Scale bar, 50 μm.(B) Two independent patient samples show an increase in basal colony formation and subsequent decrease in stem colonies upon the inhibition of BCL11B, relative to control shRNA.(C) Quantification of colony size shows decreased size of mixed and stem colonies upon inhibition of BCL11B, relative to control shRNA.(D) Mixed colonies show an increase in the fraction of basal cells when BCL11B is inhibited, relative to control. For (B--D), n = 3 independent experiments per patient, with a total of 139 patient 1 shCntrl colonies, 150 patient 1 shBCL11B colonies, 115 patient 2 shCntrl colonies, and 87 patient 2 shBCL11B colonies.(E) Four representative immunofluorescence images of primary human mammary tissue stained for BCL11B (red), Ki-67 (green), and DAPI (blue). The dotted regions are enlarged at right, and individual channels are depicted. The two fields on the left show examples of BCL11B^+^/Ki-67^+^ cells, while the two fields on the right show examples of BCL11B^+^/Ki-67^−^ and BCL11B^−^/Ki-67^+^ cells (n = 3 independent patient samples). Scale bars, 20 μm.(F) Quantification of Ki-67 staining from (E). Plotted is the percentage of BCL11B-negative cells (black bar) and BCL11B-positive cells (gray bar) that expressed Ki-67 (n = 3 independent patient samples).Error bars represent mean ± SD. ^∗^p \< 0.05 by Student\'s t test.

In addition to the shift in colony ratios, stem colonies and colonies of mixed lineage were significantly smaller when BCL11B expression was inhibited, indicating decreased self-renewal of the bipotent cells that give rise to these colonies ([Figure 6](#fig6){ref-type="fig"}C). Mixed lineage colonies also showed an increase in the fraction of basal cells within the colony, indicating a bias toward basal differentiation upon loss of BCL11B ([Figure 6](#fig6){ref-type="fig"}D).

A recent study by [@bib6] found that, in murine MECs, *Bcl11b* drives a quiescent MaSC state, inconsistent with our demonstration of a functional role of BCL11B in driving self-renewal in proliferating MaSCs. Recent advances in the study of mammary epithelial biology have raised concerns about the ability of canonical assays, such as 2D colony formation and single-cell transplantation, to drive non-physiological dedifferentiation of MECs ([@bib8], [@bib24], [@bib55]). In light of these findings, we sought to interrogate the role of BCL11B in experimental models that do not involve the isolation of single cells or culture on 2D dishes. First, we sought to determine whether BCL11B expression in human mammary cells *in vivo* was predictive of proliferation or quiescence. Immunofluorescence staining of freshly fixed human tissue showed that this was not the case, as BCL11B-positive MECs were more likely to express the proliferation marker Ki-67 than BCL11B-negative MECs ([Figures 6](#fig6){ref-type="fig"}E and 6F).

Next, to examine the functional role of BCL11B in a more native tissue development context, we turned to our hydrogel culture system. When intact, patient-derived tissue fragments consisting of hundreds of epithelial cells are seeded into hydrogels and their growth is driven by stem cell expansion, followed by differentiation ([@bib46]). To determine BCL11B\'s functional role in this *in vitro* tissue development assay, we infected patient tissues with lentiviral constructs driving the expression of either a *BCL11B*-targeting shRNA and GFP, or a control *Luciferase*-targeting shRNA and GFP ([Figure 7](#fig7){ref-type="fig"}A). This infection strategy leads to only a fraction of the cells within a tissue being transduced with the virus, allowing for the direct comparison of infected cells and wild-type cells within a single tissue. In the shLuc-GFP control, GFP-positive cells can be seen distributed throughout the tissue, in both the outer basal layer and the inner luminal layer. In contrast, in the shBCL11B-GFP infected tissues, GFP-positive cells do not contribute to new outgrowths from the tissue, and instead differentiate into elongated basal cells, restricted to the core of the structure ([Figure 7](#fig7){ref-type="fig"}B). This indicated that, in contrast with the control shRNA, inhibition of BCL11B depleted stemness and drove basal differentiation in the infected cells.Figure 7BCL11B Is Necessary for Growth of Primary Human Mammary Tissues in Hydrogel Culture(A) Schematic showing the collection of primary human mammary epithelial tissue fragments, infection of tissues with lentiviral constructs, and seeding and growth of tissues in 3D hydrogel culture.(B) Confocal microscopy images of tissues grown in culture for 14 days (representative of n = 6 independent experiments).(C) Quantification of SOX9 and SNAI2 protein in hydrogel-cultured tissues infected with lentiviral shRNA constructs driving GFP as in (A and B). Left: example of image segmentation of a representative tissue stained for SNAI2 and SOX9; segmentation analysis allows for identification of GFP-positive and -negative cells, and quantification of SNAI2 and SOX9 expression in each cell. A shCntrl-GFP tissue is depicted in this example. Right: quantification of SOX9 and SNAI2 is plotted for individual cells from shCntrl-GFP or shBCL11B-GFP infected tissues grown in hydrogels for 14 days (n = 2,187 shLuc-GFP-negative cells, 231 shLuc-GFP-positive cells, 3,678 shBCL11B GFP-negative cells, and 121 shBCL11B GFP-positive cells; three independent experiments).(D) Model of BCL11B\'s role in MaSC self-renewal and basal differentiation.Scale bars, 50 μm.

To determine the effect of BCL11B-knockdown on stem cell self-renewal and lineage commitment, we cultured patient cells in this assay for 2 weeks and then stained for expression of SNAI2 and SOX9. In MECs, SNAI2 is a marker of the basal lineage, SOX9 is a marker of the luminal lineage, and co-expression of these factors in a single cell is indicative of the MaSC state ([@bib13]). In shLuc-GFP infected control cells, we found no change in the expression of SNAI2 and SOX9, relative to uninfected control cells. However, cells infected with shBCL11B-GFP showed a marked decrease in SOX9 expression relative to tissue-matched uninfected cells ([Figure 7](#fig7){ref-type="fig"}C). This result further suggests that loss of BCL11B leads to a release from the dual-positive stem cell state and a bias toward basal differentiation, due to de-repression of basal lineage commitment of MaSCs ([Figure 7](#fig7){ref-type="fig"}D).

Discussion {#sec3}
==========

Here, we present an experimental strategy to identify TFs that control stem cell self-renewal and lineage commitment decisions. This approach directly addresses fundamentally important questions about how the stem cell\'s behavior is controlled, without the need for physically isolating distinct cell states based on marker expression. Applying this strategy to the human mammary gland identified a number of known regulators of mammary cell states (*SOX9*, *SNAI2*, and *GATA3*), as well as numerous additional candidates.

Our strategy relies on the simple assumption that factors capable of driving the specification of a cell state must be stably and actively repressed in all alternative states. While not the only way to stably repress a gene\'s expression, epigenetic modification (such as the trimethylation of histone H3K27) is one mechanism by which stable gene inactivation can occur. Thus, while our strategy cannot claim to identify all such factors, we were confident that the factors it did highlight would be enriched for functionally crucial genes.

Using a combination of canonical and recently developed 2D and 3D culture assays to assess human MaSC properties *in vitro*, we have demonstrated that one of these candidates, *BCL11B*, is required for self-renewal. *BCL11B\'s* expression is enriched in stem and progenitor cell types, relative to mature cell types, and drives MaSC self-renewal by preventing basal lineage commitment. This role is reminiscent of the role of SNAI2, an EMT TF that inhibits luminal differentiation and is required for bipotency of MaSCs. This raises the possibility that BCL11B may act as a reciprocal differentiation inhibitor, preventing basal lineage commitment, while SNAI2 prevents luminal lineage commitment.

Interestingly, a recent study also revealed a crucial role for Bcl11b in maintenance of the MaSC state in the murine mammary gland ([@bib6]). This study, however, suggested that Bcl11b expression drives quiescence in MaSCs. We find that, in human MaSCs, BCL11B-expressing cells show no indication of quiescence, as they contribute to 2D colony formation ([Figures 6](#fig6){ref-type="fig"}B--6D) and 3D tissue development ([Figures 7](#fig7){ref-type="fig"}B and 7C). In addition, BCL11B-expressing cells in fixed patient tissue sections comprise both cycling and non-cycling cells, as determined by Ki-67 staining ([Figures 6](#fig6){ref-type="fig"}E and 6F). In human MaSCs, our results suggest that BCL11B drives self-renewal by inhibiting commitment to the basal lineage and subsequent differentiation, rather than by inhibiting proliferation to drive quiescence.

While more work is needed to clarify the reason for these distinctions, it is possible that the BCL11B^+^ MaSCs in the human and mouse glands perform distinct functions. One key developmental difference between the human and murine gland is that the murine gland only produces functional terminal ductal lobular units (TDLUs) upon pregnancy, whereas the human gland undergoes more extensive development during puberty. [@bib6] limited their study to virgin mice, but the possibility remains that Bcl11b^+^ MaSCs could become proliferative once TDLUs form. This hypothesis suggests that the proliferation of BCL11B^+^ MaSCs may contribute to maintenance of the gland at this more advanced stage, although further studies are required to directly test this possibility.

Previous studies of *Bcl11b* in murine T cells suggest that its expression is regulated by numerous TFs known to also have key roles in MEC biology ([@bib22], [@bib25]). In those cells, *Bcl11b*\'s expression is controlled by a far downstream enhancer, which contains binding sites for Gata3 (a regulator of luminal fate commitment; [@bib2]), Runx1 (a regulator of stem cell differentiation; [@bib45]), and Tcf7 (a TF activated downstream of Wnt signaling, which drives MaSC self-renewal; [@bib61]). Of note, *TCF7* was also a TF that appeared in our list of Ψ-bivalent TFs, indicating that its expression may have an important role in regulating the MaSC state. While it is unknown whether these three factors activate or repress *BCL11B* transcription in the human mammary gland, this downstream enhancer could act as a central hub for MEC lineage commitment signaling.

Experimental Procedures {#sec4}
=======================

Ethics Statement {#sec4.1}
----------------

Patient reduction mammoplasty tissue samples that would otherwise have been discarded as medical waste following surgery were obtained in compliance with all relevant laws, using protocols approved by the institutional review board at Maine Medical Center. Since tissues were fully anonymized before transfer, this research was provided exemption status by the Committee on the Use of Humans as Experimental Subjects at the Massachusetts Institute of Technology. All patients enrolled in this study signed an informed consent form to agree to participate in this study and for publication of the results.

Cells and Tissues {#sec4.2}
-----------------

MCF10A cells were obtained from ATCC and cultured in mammary epithelium growth medium (MEGM) (Lonza CC-3150) supplemented with 100 ng/mL cholera toxin (Sigma-Aldrich), 1× GlutaMax, and 1× penicillin and streptomycin (Gibco). Reduction mammoplasty samples were obtained from the BioBank at Maine Medical Center. Upon arrival, tissue was chopped into roughly 3 mm^3^ fragments using a scalpel, and then incubated with 3 mg/mL collagenase (Roche) and 0.7 mg/mL hyaluronidase (Sigma-Aldrich) in MEGM at 37°C overnight. Epithelial tissue was separated from stroma by centrifugation; washed; and frozen in 90% fetal bovine serum (FBS), 10% DMSO for long-term storage. Following thawing, samples were depleted for fibroblasts via incubation at 37°C in DMEM with 10% FBS for 1 hr.

Chromatin Immunoprecipitation Sequencing {#sec4.3}
----------------------------------------

Chromatin immunoprecipitation was performed as previously described ([@bib21]). 1 × 10^8^ MCF10A cells were fixed in 11% formaldehyde solution for 10 min at room temperature (RT), quenched with 100 mM glycine, and collected by scraping. Cells were lysed in LB1 (lysis buffer 1) for 10 min at 4°C, and resuspended in LB2 for 10 min at RT. Cells were then resuspended in LB3 for sonication. Samples were sonicated for 5 min total (30 s × 10 with 1 min gaps; 18--21 W; QSonica microtip sonicator). Following sonication, samples were spun at 20,000 *g* and split into three tubes (for H3K4me3, H3K27me3, H3K79me2). At this time, 50 μL was saved as an input control.

Magnetic beads (Dynabeads; Invitrogen) were prepared by washing in block (0.5% BSA in PBS) followed by an overnight incubation at 4°C in the appropriate antibody (\[H3K4me3; Millipore \#07-473; lot JBC 1888194; 1:50\], \[H3K27me3; Abcam Ab6002; lot GR 19843-1; 1:20\], or \[H3K79me2; Abcam Ab3594-100; lot 803369; 1:50\]). In addition, 25 μL of antibody-bound beads was added to the sonicated sample and incubated overnight at 4°C on a rotator.

The samples were washed with buffers B, C, and I, and eluted in 200 μL of elution buffer at 65°C for 15 min. Crosslinks were reversed overnight at 65°C. Samples were then digested for 2 hr with 400 μg/mL RNase A at 37°C followed by 400 μg/mL Proteinase K digestion at 55°C for 2 hr. DNA was then extracted with phenol:chloroform:isoamyl and pelleted with ice-cold ethanol. Samples were resuspended in water and analyzed on a 1% agarose gel.

Samples were sequenced at the Whitehead Genome Technology Core using the Illumina HiSeq 2000 platform and TruSeq adapters. Reads were aligned to the hg38 reference genome using Bowtie2 (version 2.3.1) ([@bib20]) using default parameters except that up to one mismatch was accepted in the seed sequence. Peaks were identified by MACS2 (version 2.1.1) ([@bib62]) using the input sample as a control while bypassing the shifting model and with the broad peak setting with a broad cutoff of 0.05 for H3K4me3 and H3K79me2 conditions. To determine bivalence, peaks were first associated with their closest gene, where antisense genes were collapsed onto their respective genes, using the HOMER software suite (version 4.9.1) ([@bib15]). Next, peaks were filtered to keep only peaks within 20 kb upstream or 5 kb downstream of a transcriptional start site. Genes that retained a H3K4me3 peak and a H3K27me3 peak were identified as bivalent. These genes were then visually inspected to eliminate false-positives, yielding a final set of 55 bivalent genes.

Immunofluorescence {#sec4.4}
------------------

Immunofluorescence was performed as previously described for 2D ([@bib45]) and 3D ([@bib28], [@bib46]) culture. Antibodies and stains used were BCL11B (Cell Signaling, 12120; 1:200), KRT14 (Life Technologies, RB-9020-P; 1:300), KRT8/18 (Vector, VP-C407; 1:500), SNAI2 (Cell Signaling, 9585; 1:400), SOX9 (Sigma, WH0006662M2; 1:50), Ki-67 (Cell Signaling, 9449; 1:800), DAPI (Life Technologies, D1306), Phalloidin-AF647 (Life Technologies, A22287; 1:100), anti-rabbit IgG- AF488 (Cell Signaling, 4,412, 1:1,000), and anti-mouse IgG-AF555 (Cell Signaling, 4409, 1:1,000).

Immunofluorescence on human tissue was performed as previously described ([@bib43]). Primary and secondary antibodies used were BCL11B (Cell signaling, 12120; 1: 100), Ki-67 (Cell Signaling, 9585; 1: 400), anti-Rabbit IgG-AF555 (Life Technologies, A21430; 1:500), and anti-Mouse IgG-AF488 (Life Technologies, A11001; 1:500). Sections were treated with ProLong Gold antifade reagent with DAPI (Life Technologies, P36935) and mounted with coverslips.

Microscopy {#sec4.5}
----------

Epifluorescence microscopy for imaging of 2D colony assays was done using a Nikon TE-2000 microscope. Microscopy of immunofluorescence stained hydrogel cultures and BCL11B in MCF10A cells was done using a Zeiss LSM-700 confocal microscope. Brightfield microscopy was done using a Zeiss Axiovert 25.

RT-PCR {#sec4.6}
------

RNA was collected from MCF10A cells in 2D culture using RNeasy kit (Qiagen) and treated with RNase-free DNase (Qiagen). RNA was reverse transcribed into cDNA using iScript (Bio-Rad). PCR was run using ExTaq (Takara) and primers listed in [Table S2](#mmc1){ref-type="supplementary-material"} for 40 cycles. PCR product was run on a 4% agarose gel and detected with ethidium bromide (Sigma).

Single-Cell Real-Time qRT-PCR {#sec4.7}
-----------------------------

One cell per well was sorted using a flow cytometer into 96-well plates and lysed using CellsDirect Kit (Thermo Fisher). Genomic DNA was degraded using DNase I (Thermo Fisher). Reverse transcription was performed using SuperScript III (Thermo Fisher) and pooled pre-amplification primers at 50 nM each (see [Table S3](#mmc1){ref-type="supplementary-material"}). Twenty cycles of pre-amplification PCR were performed using CellsDirect Kit (Thermo Fisher) and pooled primers listed in [Table S3](#mmc1){ref-type="supplementary-material"}. Free primers were degraded using Exonuclease I (New England BioLabs).

Pre-amped single-cell cDNA was then used to perform real-time qRT-PCR using SsoFast EvaGreen Gene Expression (Fluidigm) protocols with 96.96 Dynamic Array plates on a BioMark HD System (Fluidigm). Primers used are listed in [Table S2](#mmc1){ref-type="supplementary-material"}.

Computational Analyses and Statistics {#sec4.8}
-------------------------------------

Clustering and principal component analysis were performed using MATLAB. All statistics were calculated using GraphPad Prism.

Colony Assay {#sec4.9}
------------

Primary mammary tissue from elective reduction mammoplasties was dissociated to single cells and plated at clonogenic density in tissue culture plates with the addition of either shLuc (shCntrl) or shBCL11B lentivirus. Colonies were grown for 10 days and then fixed and stained using immunofluorescence for expression of KRT14 and KRT8/18. Colonies were classified as luminal, basal, mixed, or stem using CellProfiler. Briefly, cells were first identified using DAPI. Corresponding KRT14 and KRT8/18 signal was then scored for each cell. Colonies in which all cells expressed KRT14 only were classified as basal. Colonies in which all cells expressed KRT8/18 only were classified as luminal. Colonies with a mixture of KRT14-only and KRT8/18-only cells were classified as mixed. Colonies with cells that co-expressed KRT14 and KRT8/18 were classified as stem.

3D Culture {#sec4.10}
----------

3D culture of primary tissue fragments using hydrogels was performed as previously described ([@bib28], [@bib46]). Culture of MCF10A cell lines in collagen gels was performed as previously described ([@bib45]).

Lentiviral Production and Infection {#sec4.11}
-----------------------------------

Lentivirus production and cell line infection were performed as previously described ([@bib14]). To infect tissue fragments, tissues were cultured overnight in MEGM supplemented with 10 μg/mL protamine sulfate and concentrated lentivirus in ultra-low attachment tissue culture plates. After overnight incubation, tissue fragments were seeded into hydrogel cultures.
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Accession Numbers {#app1}
=================

The accession number for ChIP-seq data reported in this paper is GEO: [GSE109721](ncbi-geo:GSE109721){#intref0010}.
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